Status:
COMPLETED
Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib
Lead Sponsor:
Puma Biotechnology, Inc.
Conditions:
Healthy Subjects
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to examine whether co-administration of rifampin with neratinib has an effect on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or excretes) of n...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Healthy men or women (of non childbearing potential)
- Ages 18 to 50 years old.
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00864487
Start Date
April 1 2009
End Date
May 1 2009
Last Update
May 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miami, Florida, United States, 33126